# Allelic Variants in Arhgef11 via the Rho-Rock Pathway Are Linked to Epithelial–Mesenchymal Transition and Contributes to Kidney Injury in the Dahl Salt-Sensitive Rat

**Authors:** Zhen Jia, Ashley C. Johnson, Xuexiang Wang, Zibiao Guo, Albert W. Dreisbach, Jack R. Lewin, Patrick B. Kyle, Michael R. Garrett

PMC · DOI: 10.1371/journal.pone.0132553 · PLoS ONE · 2015-07-14

## TL;DR

Variants in the Arhgef11 gene are linked to kidney injury in a rat model through changes in cell behavior and function.

## Contribution

This study identifies a novel role for Arhgef11 variants in promoting kidney injury via Rho-ROCK signaling and epithelial-mesenchymal transition.

## Key findings

- Arhgef11 knockdown reduces RhoA activity and Rho-ROCK signaling in cell lines.
- Increased Arhgef11 expression in S rats correlates with epithelial-mesenchymal transition markers.
- S rat-derived cells show impaired albumin uptake compared to controls.

## Abstract

Previously, genetic analyses identified that variants in Arhgef11 may influence kidney injury in the Dahl salt-sensitive (S) rat, a model of hypertensive chronic kidney disease. To understand the potential mechanism by which altered expression and/or protein differences in Arhgef11 could play a role in kidney injury, stably transduced Arhgef11 knockdown cell lines as well as primary cultures of proximal tubule cells were studied. Genetic knockdown of Arhgef11 in HEK293 and NRK resulted in reduced RhoA activity, decreased activation of Rho-ROCK pathway, and less stress fiber formation versus control, similar to what was observed by pharmacological inhibition (fasudil). Primary proximal tubule cells (PTC) cultured from the S exhibited increased expression of Arhgef11, increased RhoA activity, and up regulation of Rho-ROCK signaling compared to control (small congenic). The cells were also more prone (versus control) to TGFβ-1 induced epithelial-mesenchymal transition (EMT), a hallmark feature of the development of renal interstitial fibrosis, and characterized by development of spindle shape morphology, gene expression changes in EMT markers (Col1a3, Mmp9, Bmp7, and Ocln) and increased expression of N-Cadherin and Vimentin. S derived PTC demonstrated a decreased ability to uptake FITC-albumin compared to the small congenic in vitro, which was confirmed by assessment of albumin re-uptake in vivo by infusion of FITC-albumin and immunofluorescence imaging. In summary, these studies suggest that genetic variants in the S form of Arhgef11 via increased expression and/or protein activity play a role in promoting kidney injury in the S rat through changes in cell morphology (Rho-Rock and/or EMT) that impact the function of tubule cells.

## Linked entities

- **Genes:** ARHGEF11 (Rho guanine nucleotide exchange factor 11) [NCBI Gene 9826], RHOA (ras homolog family member A) [NCBI Gene 387], col1a1b (collagen, type I, alpha 1b) [NCBI Gene 325675], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], BMP7 (bone morphogenetic protein 7) [NCBI Gene 655], OCLN (occludin) [NCBI Gene 100506658], CadN (Cadherin-N) [NCBI Gene 35070], PRELID1 (PRELI domain containing 1) [NCBI Gene 737446]
- **Chemicals:** fasudil (PubChem CID 3547)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Vim (vimentin) [NCBI Gene 81818], CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, LIMK1 (LIM domain kinase 1) [NCBI Gene 3984] {aka LIMK, LIMK-1}, CFL1 (cofilin 1) [NCBI Gene 1072] {aka CFL, HEL-S-15, cofilin}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 81687], SRF (serum response factor) [NCBI Gene 6722] {aka MCM1}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Rhoa (ras homolog family member A) [NCBI Gene 117273] {aka Arha, Arha2}, Bmp7 (bone morphogenetic protein 7) [NCBI Gene 85272] {aka BMP-7}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, Cgnl1 (cingulin-like 1) [NCBI Gene 315795] {aka RGD1304623}, Alb (albumin) [NCBI Gene 24186] {aka Alb1, Albza}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRISPLD2 (cysteine rich secretory protein LCCL domain containing 2) [NCBI Gene 83716] {aka CRISP11, LCRISP2, LGL1}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, Nrk (Nik related kinase) [NCBI Gene 315907] {aka RGD1566163}, RHO (rhodopsin) [NCBI Gene 6010] {aka CSNBAD1, OPN2, RP4}, ROCK1 (Rho associated coiled-coil containing protein kinase 1) [NCBI Gene 6093] {aka P160ROCK, ROCK-I}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, CCN2 (cellular communication network factor 2) [NCBI Gene 1490] {aka CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2}, Rock1 (Rho-associated coiled-coil containing protein kinase 1) [NCBI Gene 81762] {aka P160Rock, ROCK-I}, Cdh2 (cadherin 2) [NCBI Gene 83501] {aka N-cadherin}, RAB38 (RAB38, member RAS oncogene family) [NCBI Gene 23682] {aka NY-MEL-1, rrGTPbp}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, Rho (rhodopsin) [NCBI Gene 24717], RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, Arhgef2 (Rho/Rac guanine nucleotide exchange factor 2) [NCBI Gene 310635], NRK (Nik related kinase) [NCBI Gene 203447] {aka NESK}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Ocln (occludin) [NCBI Gene 83497], INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Arhgef28 (Rho guanine nucleotide exchange factor 28) [NCBI Gene 361882] {aka Rgnef}, Arhgef11 (Rho guanine nucleotide exchange factor 11) [NCBI Gene 78966] {aka Gtrap48}, LPA (lipoprotein(a)) [NCBI Gene 4018] {aka AK38, APOA, LP}, ARHGEF11 (Rho guanine nucleotide exchange factor 11) [NCBI Gene 9826] {aka GTRAP48, PDZ-RHOGEF}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, Limk1 (LIM domain kinase 1) [NCBI Gene 65172]
- **Diseases:** genetic defect (MESH:D030342), renal pelvic carcinoma (MESH:D010386), PTC (MESH:D007673), metabolic, inflammatory diseases (MESH:D008659), fibrosis (MESH:D005355), glomerular injury (MESH:D007674), hematuria (MESH:D006417), atrophy (MESH:D001284), mesangial expansion (MESH:C537346), decline in renal function (MESH:D060825), impaired glucose tolerance (MESH:D018149), psychiatric disorders (MESH:D001523), cardiovascular diseases (MESH:D002318), renal function (MESH:D058186), renal protective (MESH:D006030), diabetic glomerulosclerosis (MESH:D003928), FHH (MESH:D006973), diabetes (MESH:D003920), schizophrenia (MESH:D012559), glomerular and tubular injury (MESH:D015499), inflammatory (MESH:D007249), tubulointerstitial injury (MESH:D009395), renal failure (MESH:D051437), CKD (MESH:D051436), Proteinuria (MESH:D011507), acute tubular necrosis (MESH:D007683), intracranial aneurysm (MESH:D002532), tubular injury (MESH:D000230), glomerulosclerosis (MESH:D005921),  (MESH:D004195)
- **Chemicals:** Alexa 488 (-), TRIzol (MESH:C411644), isoflurane (MESH:D007530), S (MESH:D013455), formalin (MESH:D005557), PBS (MESH:D007854), Hydrocortisone (MESH:D006854), NaCl (MESH:D012965), DAB (MESH:C000469), paraformaldehyde (MESH:C003043), Salt (MESH:D012492), Triton X (MESH:D017830), Y-27632 (MESH:C108830), puromycin (MESH:D011691), fasudil (MESH:C049347), F (MESH:D005461), Streptomycin (MESH:D013307), CO2 (MESH:D002245), hematoxylin (MESH:D006416), SYBR-green (MESH:C098022), FITC-Dextran (MESH:C015219), polybrene (MESH:D006583), methyl green (MESH:D008739), FITC (MESH:D016650), Alcian blue (MESH:D000423), Creatinine (MESH:D003404), GTP (MESH:D006160), Penicillin (MESH:D010406), GDP (MESH:D006153), Selenium (MESH:D012643), paraffin (MESH:D010232)
- **Species:** Homo sapiens (human, species) [taxon 9606], Lentivirus (genus) [taxon 11646], Rattus norvegicus (brown rat, species) [taxon 10116], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Mutations:** R1467H
- **Cell lines:** CRL-1571 — Homo sapiens (Human), Hypophosphatasia, Finite cell line (CVCL_W031), NRK — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_3758), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), shRNA3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_A9BB), Dahl S — Homo sapiens (Human), Colorectal adenoma, Cancer cell line (CVCL_8754), HEK293T/17 — Homo sapiens (Human), Transformed cell line (CVCL_1926), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), CRL-11268 — Homo sapiens (Human), Frontotemporal dementia, Transformed cell line (CVCL_HR73), pPTC — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_TZ66), H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), LVC +F — Mesocricetus auratus (Golden hamster), Transformed cell line (CVCL_XK46)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4501567/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4501567/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC4501567/full.md

---
Source: https://tomesphere.com/paper/PMC4501567